结直肠癌TNM分期(第八版)、新版本、新记法

2016-12-29 全球结直肠医学高峰论坛 结直肠癌TNM分期(第八版)、新版本、新

2016年12月, UICC(国际抗癌联盟)发布了第八版的恶性肿瘤的TNM分期。由James Brierley教授,前UICC主席Mary Gospodarowicz James 教授(加拿大多伦多大学玛格丽特公主癌症中心)和Christian Wittekind教授(德国莱比锡大学医院)编辑,它提供了最新的,国际公认标准来描述和归类癌症的分期。

"margin: 0px; padding: 0px; max-width: 100%; font-family: 宋体; box-sizing: border-box !important; word-wrap: break-word !important;">为IIIC期。欢迎关注全球结直肠医学高峰论坛公众号,及时提供国内外最新结直肠肿瘤咨询,免费提供英文原版TNM分期新版本。2016年12月, UICC(国际抗癌联盟)发布了第八版的恶性肿瘤的TNM分期。由James Brierley教授,前UICC主席Mary Gospodarowicz James 教授(加拿大多伦多大学玛格丽特公主癌症中心)和Christian Wittekind教授(德国莱比锡大学医院)编辑,它提供了最新的,国际公认标准来描述和归类癌症的分期。其中结直肠癌新版本分期的改变不大,主要的是肿瘤种植的定义及M(远处转移)分期有所改变,具体描述如下。同时笔者提供简单记忆方法供同行参考。原发肿瘤(T)Tx    原发肿瘤无法评价T0 &nbs

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952219, encodeId=1f60195221986, content=<a href='/topic/show?id=d62f1e60618' target=_blank style='color:#2F92EE;'>#TNM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17606, encryptionId=d62f1e60618, topicName=TNM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Fri Aug 11 09:02:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376665, encodeId=005213e66655a, content=<a href='/topic/show?id=c0261e607d0' target=_blank style='color:#2F92EE;'>#TNM分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17607, encryptionId=c0261e607d0, topicName=TNM分期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb32388, createdName=linne320, createdTime=Sat Dec 31 03:02:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452866, encodeId=1bb614528662b, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Dec 31 03:02:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
    2017-08-11 Eleven11
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952219, encodeId=1f60195221986, content=<a href='/topic/show?id=d62f1e60618' target=_blank style='color:#2F92EE;'>#TNM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17606, encryptionId=d62f1e60618, topicName=TNM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Fri Aug 11 09:02:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376665, encodeId=005213e66655a, content=<a href='/topic/show?id=c0261e607d0' target=_blank style='color:#2F92EE;'>#TNM分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17607, encryptionId=c0261e607d0, topicName=TNM分期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb32388, createdName=linne320, createdTime=Sat Dec 31 03:02:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452866, encodeId=1bb614528662b, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Dec 31 03:02:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952219, encodeId=1f60195221986, content=<a href='/topic/show?id=d62f1e60618' target=_blank style='color:#2F92EE;'>#TNM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17606, encryptionId=d62f1e60618, topicName=TNM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Fri Aug 11 09:02:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376665, encodeId=005213e66655a, content=<a href='/topic/show?id=c0261e607d0' target=_blank style='color:#2F92EE;'>#TNM分期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17607, encryptionId=c0261e607d0, topicName=TNM分期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb32388, createdName=linne320, createdTime=Sat Dec 31 03:02:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452866, encodeId=1bb614528662b, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Dec 31 03:02:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]

相关资讯

NCCN乳腺癌临床实践指南2016.2版(1)

NCCN乳腺癌临床实践指南2016.2版(1)

ce

ce

NCCN乳腺癌临床实践指南2016.2版(1)

非浸润性乳腺癌: l小叶原位癌(LCIS-1) l导管原位癌(DCIS)检查和主要治疗(DCIS-1) l导管原位癌术后治疗和监测/随访(DCIS-2) l导管原位癌切缘状况(DCIS-A

修改

修改

NCCN乳腺癌临床实践指南2016.2版(1)

非浸润性乳腺癌: l小叶原位癌(LCIS-1) l导管原位癌(DCIS)检查和主要治疗(DCIS-1) l导管原位癌术后治疗和监测/随访(DCIS-2) l导管原位癌切缘状况(DCIS-A)

虚不受补的中国医疗,如何调理?一位医生这么认为……

本文先说为什么“虚”,然后再说为什么不能大补,最后说怎么调理。